Sunday 18 October 2026
Export IVF’s income statement to Excel — free account
INVO Fertility, Inc
IVF Healthcare Medical Devices
INVO Fertility, Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 4.74% from fiscal 2024. In the quarter to June 2026, revenue grew 16.7%, EPS grew 100.1%, free cash flow grew 35.1% and total debt fell 50.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
0.56
0.03
−5.08%
Follow IVF
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 4 | 4 | 7 | 6 | 5 | 2 | 5 | 4 | 4 |
P/S ratio |
883,505,236.93 | 69,243,011.43 | 115,368,949.17 | 26.92 | 16.71 | 9.22 | 6.15 | 0.61 | 0.54 | 0.06 |
Altman Z-Score |
5,492,046.57 | 2,302,209.30 | 9,771,514.27 | (16.71) | (2.79) | 1.42 | (28.27) | (5.79) | (2.75) | (7.60) |
Altman Z″-Score (non-manufacturers) |
(358.54) | (365.79) | (138.07) | (50.60) | (6.88) | (9.86) | (68.02) | (14.98) | (7.70) | (19.01) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 30.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(30.06) | (3.39) | (16.27) | (8.55) | (1.80) | 4.79 | — | (1.59) | (2.46) | (1.33) |
P/Operating CF |
(455,655,492.75) | (1,001,715,565.31) | (199,116,171.69) | (51.68) | (9.52) | (25.39) | (5.04) | (2.58) | (5.67) | 17.50 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 3.02 | 5.25 | 0.00 | 0.00 | 0.00 | 0.09 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 3.07 | 5.34 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
883,505,236.72 | 69,243,011.84 | 115,368,949.44 | 26.34 | 7.55 | 8.37 | 9.28 | 1.64 | 1.41 | (0.11) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 |
EV/Operating CF |
(138,567,662.94) | (107,741,057.03) | (87,330,584.54) | 28.45 | (1.64) | (5.77) | (1.16) | (1.04) | (3.09) | 0.11 |
EV/FCF |
(138,567,662.94) | (107,741,057.03) | (87,330,584.54) | 29.86 | (1.61) | (5.34) | (1.15) | (0.95) | (2.98) | 0.11 |
Quick Ratio |
0.03 | 0.02 | 0.13 | 0.83 | 4.42 | 4.58 | 0.05 | 0.05 | 0.04 | 0.22 |
Current Ratio |
0.05 | 0.05 | 0.21 | 1.03 | 4.61 | 5.03 | 0.19 | 0.16 | 0.07 | 0.27 |
Net Debt/EBITDA |
0.01 | (0.50) | 0.02 | 0.61 | 3.18 | 0.98 | (0.15) | (0.17) | (0.10) | 0.25 |
Debt/Assets |
49.51% | 128.60% | 20.20% | 20.94% | 5.43% | 18.17% | 45.02% | 6.78% | 2.45% | 3.68% |
Debt/Equity |
(0.03) | (0.07) | (0.06) | (0.10) | 0.10 | 0.26 | (1.71) | 1.40 | 0.09 | 0.10 |
Asset Turnover |
0.12 | 1.02 | 0.95 | 1.15 | 0.16 | 0.39 | 0.12 | 0.27 | 0.20 | 0.21 |
Operating CF/Net income |
0.15 | 0.26 | 0.21 | (0.63) | 0.57 | 0.91 | 0.61 | 0.59 | 0.31 | 0.28 |
Capex/Depreciation |
(8.26) | 0.00 | (0.05) | (0.32) | (0.04) | (0.34) | (0.10) | (0.48) | (0.07) | (0.02) |
Interest Coverage |
(152.93) | (30.64) | (5.96) | (4.60) | (1.94) | (4.12) | (178.90) | (7.31) | (6.40) | (5.56) |
| 50.73% | 14.61% | 79.73% | 67.34% | (822.60%) | (101.96%) | (343.99%) | 264.08% | 83.06% | 387.43% | |
| (490.60%) | (254.14%) | (589.46%) | (168.49%) | (131.01%) | (62.16%) | (153.67%) | (72.33%) | (29.45%) | (75.81%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (92.43%) | (1,102.70%) | (220.95%) | (31.64%) | (76.78%) |
Return on Tangible Assets |
47.15% | 14.40% | 112.43% | (1,600.81%) | (99.53%) | (119.82%) | 477.70% | 135.80% | 58.90% | 349.81% |
Average Days of Receivables |
20.08 | 112.18 | 166.77 | 1.87 | 7.64 | 4.43 | 34.23 | 16.99 | 6.32 | 11.59 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 38.41% | 5.20% | 66.16% | 5.49% | 0.08% | 0.00% |
Selling, General and Administrative Expense of Revenue |
4,216.50% | 308.61% | 614.50% | 211.36% | 584.70% | 216.71% | 1,213.40% | 247.85% | 123.48% | 112.42% |
Intangible Assets out of Total Assets |
0.07 | 0.06 | 0.02 | 0.03 | 0.01 | 0.01 | 0.00 | 0.54 | 0.20 | 0.36 |
Share Based Compensation of Revenue |
2,482.51% | 76.25% | 423.28% | 4.31% | 59.38% | 27.99% | 73.95% | 11.40% | 19.09% | 18.86% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | (0.10) | 0.31 | 0.08 | (0.80) | (8.87) | (9.21) | (23.20) |
Graham Number |
0.11 | 0.06 | 0.09 | 48,563.72 | 0.00 | 0.00 | 37,763.13 | 30,214.18 | 21,583.50 | 1,220.36 |
Earnings Yield |
0.00% | 0.00% | 0.00% | (2.83%) | (50.71%) | (18.83%) | (205.11%) | (430.99%) | (299.32%) | 42,636.66% |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 3.28% | (28.06%) | (16.98%) | (130.82%) | (282.20%) | (88.15%) | (1,600.54%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 7,401.00 | 5,186.50 | 10,400.25 | 2,055.50 | 3,020.60 | 2,177.33 | 58.47 |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 6,852.50 | (23,875.50) | (15,074.75) | (16,508.25) | (4,755.10) | (991.47) | (59.95) |
Capex per Share |
0.00 | 0.00 | 0.00 | (573.50) | (445.00) | (1,136.50) | (31.75) | (444.70) | (36.03) | (0.37) |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 6,279.00 | (24,320.50) | (16,211.25) | (16,540.00) | (5,199.80) | (1,027.50) | (60.32) |
Cash per Share |
0.00 | 0.00 | 0.00 | 6,193.00 | 50,489.00 | 14,212.25 | 225.25 | 232.40 | 206.50 | 17.76 |
Shareholders Equity per Share |
(0.03) | (0.04) | (0.02) | (18,568.00) | 28,715.50 | 18,276.75 | (2,444.00) | 892.60 | 4,194.80 | 61.75 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.03) | (0.04) | (0.02) | (18,568.00) | 28,715.50 | 18,276.75 | (2,444.00) | 892.60 | 4,194.80 | 61.75 |
Free Cash Flow |
(0.34) | (0.18) | (0.67) | 1.26 | (4.86) | (6.48) | (6.62) | (5.20) | (3.08) | (7.06) |
Working Capital |
(4.52) | (4.89) | (2.77) | 0.04 | 8.25 | 5.05 | (2.72) | (6.74) | (16.61) | (7.57) |
Capital Expenditures |
(0.02) | — | (0.02) | (0.11) | (0.09) | (0.45) | (0.01) | (0.44) | (0.11) | (0.04) |
Net Current Asset Value |
(4.65) | (5.02) | (2.77) | (3.97) | 5.34 | 3.15 | (4.07) | (16.35) | (32.24) | (10.23) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
Capex to Sales |
0.31 | 0.00 | 0.04 | 0.08 | 0.09 | 0.11 | 0.02 | 0.15 | 0.02 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.12 | 0.18 | 10.79 | 3.90 | 19.13 | 2.70 | 0.30 | 1.11 | 3.30 | 4.82 |
Cash ROIC |
7.85% | 3.92% | 28.55% | (59.83%) | (29.59%) | (43.53%) | (845.50%) | (218.57%) | (21.51%) | (70.25%) |
Accounts Receivable Turnover |
24.83 | 6.30 | 3.16 | 12.68 | 70.81 | 115.24 | 12.89 | 27.75 | 51.49 | 41.41 |
Accounts Payable Turnover |
0.02 | 0.05 | 0.12 | 0.28 | 0.25 | 0.38 | 0.95 | 1.05 | 1.34 | 1.68 |
Inventory Turnover |
0.20 | 0.72 | 1.77 | 1.85 | 0.48 | 0.52 | 3.09 | 7.33 | 15.11 | 19.38 |
Average Days of Payables |
23,565.46 | 6,743.38 | 2,308.71 | 1,014.19 | 1,351.90 | 1,115.38 | 578.73 | 439.72 | 310.71 | 172.15 |
Days of Inventory on Hand |
2,059.47 | 413.43 | 175.64 | 276.82 | 1,090.89 | 723.96 | 113.09 | 49.91 | 21.93 | 19.07 |
Average Receivables |
0.00 | 0.04 | 0.16 | 0.12 | 0.01 | 0.04 | 0.06 | 0.11 | 0.13 | 0.17 |
Average Payables |
1.00 | 0.97 | 0.77 | 0.47 | 0.35 | 0.39 | 0.90 | 1.84 | 2.72 | 2.57 |
Average Inventory |
0.08 | 0.07 | 0.05 | 0.07 | 0.18 | 0.28 | 0.28 | 0.26 | 0.24 | 0.22 |
Average Assets |
0.43 | 0.28 | 0.52 | 1.29 | 6.37 | 10.71 | 7.09 | 11.11 | 32.29 | 33.15 |
Average Common Equity |
(4.19) | (4.80) | (3.86) | (3.22) | 1.01 | 6.53 | 3.17 | (3.04) | (11.45) | (6.49) |
Columns are period end dates